Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/23/1994 | WO1994013305A1 Method of ophthalmic drug delivery |
06/23/1994 | WO1994013304A2 Antacid composition and method of production |
06/23/1994 | WO1994013303A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
06/23/1994 | WO1994013302A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
06/23/1994 | WO1994013300A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
06/23/1994 | WO1994013299A1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
06/23/1994 | WO1994013298A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries |
06/23/1994 | WO1994013297A1 Potassium channel activators and use thereof in therapy |
06/23/1994 | WO1994013296A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries |
06/23/1994 | WO1994013295A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
06/23/1994 | WO1994013294A1 Triazoloquinazolines for the treatment of diseases of the central nervous system |
06/23/1994 | WO1994013293A2 (quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes |
06/23/1994 | WO1994013292A1 Potassium channel activators for use in therapy |
06/23/1994 | WO1994013291A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives |
06/23/1994 | WO1994013289A1 Pharmaceutical compound with anti-ulcer properties |
06/23/1994 | WO1994013288A1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries |
06/23/1994 | WO1994013287A1 Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug |
06/23/1994 | WO1994013286A1 Method of treating impaired immune functions |
06/23/1994 | WO1994013285A1 Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development |
06/23/1994 | WO1994013284A1 New use of 5-ht3 receptor antagonists |
06/23/1994 | WO1994013283A1 Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac |
06/23/1994 | WO1994013282A1 Treatment of lymes disease and associated debilitating conditions |
06/23/1994 | WO1994013281A1 Anti-inflammatory and analgesic gel preparation |
06/23/1994 | WO1994013280A1 Sprayable analgesic composition and method of use |
06/23/1994 | WO1994013279A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
06/23/1994 | WO1994013278A1 Methods for treatment with dimercaptosuccinic acid (dmsa) |
06/23/1994 | WO1994013277A2 Use of dinaphthalenes compounds as antiproliferative agents |
06/23/1994 | WO1994013276A1 4-guanidinobutyramide for improving blood circulation |
06/23/1994 | WO1994013275A1 Glaucoma treatment |
06/23/1994 | WO1994013274A1 Stabilized catecholamine solutions |
06/23/1994 | WO1994013272A1 Use of potassium channel activators for the manufacture of a medicament for the treatment of pain |
06/23/1994 | WO1994013271A1 System for dispensing pharmaceutically active compounds |
06/23/1994 | WO1994013267A1 Veterinary medicament |
06/23/1994 | WO1994013265A1 A free radical quenching liposomal composition |
06/23/1994 | WO1994013263A1 Stabilized medicinal aerosol solution formulations |
06/23/1994 | WO1994013262A1 Stabilized medicinal aerosol solution formulations |
06/23/1994 | WO1994013261A1 Aqueous antibiotic composition for veterinary use |
06/23/1994 | WO1994013260A2 Use of a simarouba extract to reduce patchy skin pigmentation |
06/23/1994 | WO1994013254A1 Antiplaque, antigingivitis, anticaries oral composition |
06/23/1994 | WO1994008578A3 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
06/23/1994 | WO1994003467A3 Antiretroviral enantiomeric nucleotide analogs |
06/23/1994 | WO1994003149A3 Lipid-soluble thioethers and dithioethers in cosmetic preparations to counteract aging of the human skin |
06/23/1994 | DE4305553A1 Topical pharmaceutical or cosmetic compsn - contg. N-acyl-alkanolamine and phosphatidyl-ethanolamine derivs., e.g. for protecting skin against light or treating insect stings |
06/23/1994 | DE4305552A1 Topical pharmaceutical or cosmetic compsn - contg N-acyl-alkanolamine, used for e.g. protecting skin against light or treating insect bites |
06/23/1994 | DE4243363A1 Treatment of dry skin |
06/23/1994 | DE4243362A1 Agent for treating skin dryness and neuro:endocrine and immune system |
06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
06/23/1994 | CA2151747A1 Methods for treatment with dimercaptosuccinic acid (dsma) |
06/23/1994 | CA2151734A1 4-guanidinobutyramide for improving blood circulation |
06/23/1994 | CA2151603A1 Application of anticonvulsant in the treatment of neurological lesions associated with traumas |
06/23/1994 | CA2151601A1 Application of lamotrigin in the treatment of neurological lesions associated with traumas |
06/23/1994 | CA2151585A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
06/23/1994 | CA2151515A1 Bicyclic compounds with pharmaceutical activity |
06/23/1994 | CA2151495A1 A free radical quenching liposomal composition |
06/23/1994 | CA2151384A1 Benzazepinone derivatives |
06/23/1994 | CA2151380A1 Substituted benzazepinones |
06/23/1994 | CA2151378A1 1,4-disubstituted 4-fused phenyl piperidines and piperazines as high-affinity ligands for 5h-t1a receptor |
06/23/1994 | CA2151282A1 Azanoradamantanes |
06/23/1994 | CA2151257A1 Dna encoding chitin deacetylase |
06/23/1994 | CA2151243A1 Novel triazolopyrimidones, their preparation and use |
06/23/1994 | CA2151242A1 Novel triazoloquinazolines, their preparation and use |
06/23/1994 | CA2151241A1 Triazoloquinazolines for the treatment of central nervous disorders |
06/23/1994 | CA2151235A1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
06/23/1994 | CA2151039A1 Idazoxan and derivatives thereof used for preparing a drug intended for the treatment of parkinsons's desease |
06/23/1994 | CA2150951A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists |
06/23/1994 | CA2150947A1 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders |
06/23/1994 | CA2150904A1 Novel selective aromatase inhibiting compounds |
06/23/1994 | CA2150903A1 Compounds for the treatment of leukemias |
06/23/1994 | CA2150711A1 Antitumour agents |
06/23/1994 | CA2150536A1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
06/23/1994 | CA2150461A1 1,4-benzodiazepine derivatives and their use as cck-modulators |
06/23/1994 | CA2150383A1 Antacid composition and method of production |
06/23/1994 | CA2150033A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
06/23/1994 | CA2149754A1 Lipid prodrugs for oral administration |
06/23/1994 | CA2149021A1 7-halo- and 7beta,8beta-methano-taxols, antineoplastic use and pharmaceutical compositions containing them |
06/23/1994 | CA2129642A1 Benzocycloheptenes, benzoxepines and benzothiepines |
06/23/1994 | CA2117462A1 New pyrimidine bicyclic compounds; process for preparing the same; pharmaceutical compositions containing them |
06/23/1994 | CA2112052A1 Inhibitors of hiv protease useful for the treatment of aids |
06/23/1994 | CA2112043A1 Inhibitors of hiv protease useful for the treatment of aids |
06/23/1994 | CA2112042A1 Inhibitors of hiv protease useful for the treatment of aids |
06/23/1994 | CA2112041A1 Inhibitors of hiv protease useful for the treatment of aids |
06/23/1994 | CA2112019A1 Inhibitors of hiv protease useful for the treatment of aids |
06/23/1994 | CA2110939A1 An innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
06/22/1994 | EP0603160A2 Compositions for in-situ active compound assembly |
06/22/1994 | EP0603112A1 Use of thrombin inhibitors for inhibiting ocular fibrin formation |
06/22/1994 | EP0603001A1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease |
06/22/1994 | EP0602961A1 Lanolin/lanolin acid ester skin treatment composition |
06/22/1994 | EP0602921A1 Bicarbonate dialysis dialysate component and method of manufacture |
06/22/1994 | EP0602878A1 Diarylsulfonylureas and their use as antitumor agents |
06/22/1994 | EP0602851A1 Quinazoline derivatives |
06/22/1994 | EP0602814A1 Crystal forms of optically active isoindolines and their use |
06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
06/22/1994 | EP0602619A1 Controlled-release pharmaceutical compositions containing nicergoline |
06/22/1994 | EP0602597A2 Process for preparation of indolopyrrolocarbazole derivatives |
06/22/1994 | EP0602586A2 Stable pharmaceutical composition of fumagillol derivatives |
06/22/1994 | EP0602585A2 Dialysis solution for a peritoneal dialysis |
06/22/1994 | EP0602523A1 Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
06/22/1994 | EP0602522A1 Substituted Benzoylguanidines, method for their preparation, their use as antiarrhythmic agents |
06/22/1994 | EP0602521A1 Imidazopyridines |
06/22/1994 | EP0602483A1 Diazepine derivatives |